SA
Sign upLog In

BMY R&D Expenses

Bristol Myers Squibb · R&D Expenses

BMY logo

BMY R&D Expenses

Latest reported$10.72B
BMY TTM R&D Expenses ($0.00 → $10.72B)
High-resolution chart · PNG

BMY r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
10,722,000,000
10,343,000,000
9,951,000,000
10,556,000,000
10,402,000,000
10,721,000,000
11,159,000,000
10,446,000,000
10,314,000,000
9,673,000,000
9,299,000,000
9,331,000,000
9,507,000,000
9,570,000,000
9,509,000,000
9,606,000,000
10,168,000,000
10,325,000,000
10,284,000,000
11,427,000,000
10,946,000,000
10,990,000,000
11,143,000,000
9,480,000,000
8,359,000,000
7,162,000,000
6,138,000,000
5,431,000,000
5,333,000,000
6,443,000,000
6,345,000,000
6,886,000,000
7,167,000,000
6,411,000,000
6,464,000,000
5,943,000,000
5,520,000,000
5,107,000,000
4,940,000,000
5,456,000,000
5,450,000,000
6,040,000,000
5,920,000,000
5,193,000,000
5,044,000,000
4,604,000,000
4,534,000,000
4,302,000,000
4,212,000,000
3,747,000,000
3,731,000,000
3,856,000,000
3,914,000,000
3,925,000,000
3,904,000,000
3,830,000,000
3,852,000,000
3,813,000,000
3,839,000,000
3,841,000,000
3,692,000,000
3,591,000,000
3,566,000,000
3,613,000,000
3,609,000,000
3,598,000,000
3,596,000,000
3,682,000,000
3,696,000,000
3,711,000,000
3,585,000,000
3,312,000,000
3,280,000,000
3,209,000,000
3,218,000,000
3,169,000,000
3,123,000,000
3,108,000,000
3,067,000,000
3,021,000,000
2,934,000,000
2,843,000,000
2,746,000,000
2,648,000,000
2,594,000,000
2,570,000,000
2,500,000,000
2,528,000,000
2,478,000,000
2,377,000,000
2,269,000,000
2,218,000,000
2,188,000,000
2,191,000,000
2,218,000,000
2,324,000,000
2,274,000,000
2,242,000,000
2,248,000,000
2,052,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.